Mucocutaneous Lymph Node Syndrome
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017
A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
Prevention of Coronary Aneurysms in Kawasaki Syndrome